However, AP1 activation, although essential, is not sufficient for the conversion of JB6- (insensitive to tumour promotion) to JB6+ phenotype, which are sensitive to tumour promotion (58), indicating that PDCD4 must modulate an additional pathway other than AP-1 regulation in these cells to suppress tumorigenesis. This evidence concerns the gene PDCD4 and neoplasm.